Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis-Reference-Cited by-同舟云学术

Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis

Published:2008-01 Issue:4 Volume:37 Page:248-254
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Book C.,Karlsson M.,Åkesson K.,Jacobsson L.

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.1080/03009740801998747

Reference31 articles.

1. BONE MASS MEASUREMENT AND BONE METABOLISM IN RHEUMATOID ARTHRITIS: A REVIEW

2. Bone Loss in Rheumatoid Arthritis: Influence of disease activity, duration of the disease, functional capacity, and corticosteroid treatment

3. Generalised and Localised Bone Loss in Patients with Rheumatoid Arthritis

4. Rheumatoid arthritis and bone mineral density in elderly women

5. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County rheumatoid arthritis register

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years;BMC Rheumatology;2023-08-07

2. Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications;Open Access Rheumatology: Research and Reviews;2022-11

3. Risk factors for osteoporosis and fractures in rheumatoid arthritis;Best Practice & Research Clinical Rheumatology;2022-09

4. Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease;Annals of the Rheumatic Diseases;2022-06-09

5. Impact of Treat-to-Target Therapy on Bone Mineral Density Loss in Patients With Rheumatoid Arthritis: A Prospective Cohort Study;Frontiers in Endocrinology;2022-05-17